Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center

Transplant Infectious Disease

Volumn 7, Issue 3-4, 2005, Pages 109-115

  Freifeld, Alison G ^a   Iwen, P C ^a   Lesiak, B L ^a   Gilroy, R K ^a   Stevens, R B ^a   Kalil, A C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Histoplasmosis; Solid organ transplants

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; DACLIZUMAB; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE DISEASE; ACUTE GRAFT REJECTION; ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG ERUPTION; DRUG MEGADOSE; DRUG TOLERABILITY; DYSPNEA; FAILURE TO THRIVE; FATIGUE; FEMALE; FEVER; FUNGUS CULTURE; GRAFT RECIPIENT; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUNG DISEASE; MALAISE; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; THORAX RADIOGRAPHY; UNITED STATES; UNIVERSITY HOSPITAL; URINALYSIS;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; NEBRASKA; ORGAN TRANSPLANTATION;

EID: 29544442209     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-8365.2005.00105.x     Document Type: Article

References (19)

1. WHEAT LJ, CONCES D, ALLEN S, BLUE-HNIDY D, LOYD J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 2004: 25: 129-144.
2. WHEAT J, SAROSI G, MCKINSEY D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000: 30: 688-695.
3. KAUFFMAN CA, ISRAEL KS, SMITH JW, WHITE AC, SCHWARZ J, BROOKS GF. Histoplasmosis in immunosuppressed patients. Am J Med 1978: 64: 923-932.
4. WHEAT LJ, SLAMA TG, NORTON JA, et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982: 96: 159-163.
5. MCKINSEY DS, SPIEGEL RA, HUTWAGNER L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997: 24: 1195-1203.
6. DAVIES SF, SAROSI GA, PETERSON PK, et al. Disseminated histoplasmosis in renal transplant recipients. Am J Surg 1979: 137: 686-691.
7. LIMAYE AP, CONNOLLY PA, SAGAR M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000: 343: 1163-1166.
8. EDWARDS PQ, BILLINGS EL. Worldwide pattern of skin sensitivity to histoplasmin. Am J Trop Med Hygiene 1971: 20: 288-319.
9. WHEAT LJ, SMITH EJ, SATHAPATAYAVONGS B, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med 1983: 143: 703-707.
10. PEDDI VR, HARIHARAN S, FIRST MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transpl 1996: 10: 160-165.
11. VAIL GM, YOUNG RS, WHEAT LJ, FILO RS, CORNETTA K, GOLDMAN M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002: 4: 148-151.
12. BOTTEREL F, ROMAND S, SALIBA F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999: 18: 662-664.
13. VINAYEK R, BALAN V, PINNA A, LINDEN PK, KUSNE S. Disseminated histoplasmosis in a patient after orthotopic liver transplantation. Clin Transplant 1998: 12: 274-277.
14. SHALLOT J, PURSELL KJ, BARTOLONE C, et al. Disseminated histoplasmosis after orthotopic liver transplantation. Liver Transpl Surg 1997: 3: 433-434.
15. WHEAT LJ, CONNOLLY-STRINGFIELD PA, BAKER RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990: 69: 361-374.
16. JOHNSON PC,WHEAT LJ, CLOUD GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002: 137: 105-109.
17. WHEAT LJ. Current diagnosis of histoplasmosis. Trends Microbiol 2003: 11: 488-493.
18. DURKIN MM, CONNOLLY PA, WHEAT LJ. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol 1997: 35: 2252-2255.
19. ESPINEL-INGROFF A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998: 36: 198-202.